|
1) Takahashi K, Tanabe K, Ooba S, et al. Prophylactic use of a new immunosuppressive agent, deoxyspergualin, in patients with kidney transplantation from ABO-incompatible or preformed antibody positive donors. Transplant Proc. 1993; 23: 1078-82
|
|
|
|
2) Takahashi K, Saito K, Takahara S, et al. The Japanese ABO-incompatible Kideny Transplantation Committee. Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan. Am J Transplant. 2004; 4: 1089-96
|
|
|
|
|
3) Takahashi K, Saito K, et al. the Japanese ABO-incompatible Kidney Transplantation Committee. Present status of ABO-incompatible kidney transplantation in Japan. Xenotransplant. 2006; 13: 118-22
|
|
|
|
|
|
4) Takahashi K. ABO-incompatible organ transplantation. Curr Opin Organ Transplant. 2007; 12: 409-14
|
|
|
|
|
|
5) Takahashi K. Accommodation in ABO-incompatible kidney transplantation: Why do kidney grafts survive？ Transplant Proc. 2004; 36(Suppl 2S): 193-6
|
|
|
|
|
|
6) Takahashi K. Accommodation in ABO-incompatible kidney transplantation. Amsterdam: Elsevier; 2004. p. 1-209
|
|
|
|
|
|
7) Takahashi K. A new concept of accommodation in ABO-incompatible kidney transplantation. Clin Transplant. 2005; 19 Suppl 14: 76-85
|
|
|
|
|
|
8) Takahashi K. ABO-incompatible kidney transplantation. Establishing a Scientific Framework. Amsterdam: Elsevier; 2007. p. 1-93
|
|
|
|
|
|
9) West LJ. B-cell tolerance following ABO-incompatible infant cardiac transplantation. Transplantation. 2006; 81: 665-71
|
|
|
|
|
|
10) West LJ, Phil D, Stacy M, et al. ABO-incompatible heart transplantation infants. N Engl J Med. 2001; 344: 793-800
|
|
|
|
|
|
11) West LJ, Karamiou T, Dipchard AI, et al. Impact on outcome after listing and transplantation of a strategy to accept ABO blood group-incompatible donor heart for neonates and infants. J Thorac Cariovasc Surg. 2006; 131: 455-61
|
|
|
|
|
|
12) Takahashi K. Resent findings in ABO-incompatible kidney transplantation‐Classification and therapeutic strategy for acute antibody-mediated rejection due to ABO-blood-group-related antigens during critical period preceding establishment of accommodation. Clin Exp Nephrol. 2007; 11: 128-41
|
|
|
|
|
|
13) Takahashi K. Pretransplant extracorporeal immunomodulation. In: Accommodation in ABO-incompatible kidney transplantation. Amsterdam; Elsevier; 2004. p. 55-65
|
|
|
|
|
|
14) Nishi S, Hasegawa S, Takahashi K, et al. The safety measures for double filtration plasma aphereis(DFPP) before ABO incompatible kidney transplantation. In: Takahashi K, editor. ABO-incompatible organ transplantation from Japan. Amsterdam: Elsevier; 2006. p. 91-5
|
|
|
|
|
|
15) Rydlerg L, Bengtsson A, Nilsson K, et al. In vitro assessment of a new ABO immunosorbent with synthetic carbohydrates attached to sepharose. Transplant Int. 2005; 17: 666-72
|
|
|
|
|
|
16) Takahashi K. Timing of the start of immunosuppressive therapy (duration of desensitization therapy). In: Accommodation in ABO-incompatible kidney transplantation. Amsterdam: Elsevier; 2004. p. 94-5
|
|
|
|
|
|
17) Saito K, Nakagawa Y, Takahashi K, et al. Pinpoint targeted immunosuppression; Anti-CD20/MMF desensitization with anti-CD25 in successful ABO-incompatible kidney transplantation without aplenectomy. Xenotransplant. 2006; 13: 111-7
|
|
|
|
|
|
18) Alexandre GPJ, Bruyere MDE, Squifflet JP, et al. ABO incompatible living donor renal homografts. Neth J Med. 1985; 28: 231-4
|
|
|
|
|
|
19) Alexandre GPJ, Squifflet JP, DeBruyere M, et al. Splenectomy as a prerequisite for successful human ABO-incompatible renal transplantation. Transplant Proc. 1985; 17: 138-43
|
|
|
|
|
|
20) Tyden G, Kumlien G, Fehrman I. Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximab. Transplantation. 2003; 5: 145-8
|
|
|
|
|
|
21) Takahashi K. A review of humoral rejection in ABO-incompatible kidney transplantation with local(intrarenal) DIC as the underlying condition. Acta Med Biol. 1997, 45: 95-102
|
|
|
|